Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component.
Yoshioka Y, Kobiyama K, Hayashi T, Onishi M, Yanagida Y, Nakagawa T, Hashimoto M, Nishinaka A, Hirose J, Asaoka Y, Tajiri M, Hayata A, Ishida S, Omoto S, Nagira M, Ishii KJ. Yoshioka Y, et al. Among authors: nagira m. Front Immunol. 2023 Feb 20;14:1116238. doi: 10.3389/fimmu.2023.1116238. eCollection 2023. Front Immunol. 2023. PMID: 36891311 Free PMC article.
Ceramide kinase is not essential but might act as an Ca2+-sensor for mast cell activation.
Mitsutake S, Kumada H, Soga M, Hurue Y, Asanuma F, Nagira M, Deguchi M, Date T, Yokose U, Inagaki Y, Sugiura M, Kohama T, Igarashi Y. Mitsutake S, et al. Among authors: nagira m. Prostaglandins Other Lipid Mediat. 2010 Nov;93(3-4):109-12. doi: 10.1016/j.prostaglandins.2010.07.003. Epub 2010 Aug 1. Prostaglandins Other Lipid Mediat. 2010. PMID: 20678580
Gata3/Ruvbl2 complex regulates T helper 2 cell proliferation via repression of Cdkn2c expression.
Hosokawa H, Tanaka T, Kato M, Shinoda K, Tohyama H, Hanazawa A, Tamaki Y, Hirahara K, Yagi R, Sakikawa I, Morita A, Nagira M, Poyurovsky MV, Suzuki Y, Motohashi S, Nakayama T. Hosokawa H, et al. Among authors: nagira m. Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18626-31. doi: 10.1073/pnas.1311100110. Epub 2013 Oct 28. Proc Natl Acad Sci U S A. 2013. PMID: 24167278 Free PMC article.
S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
Nakagawa T, Tanino T, Onishi M, Tofukuji S, Kanazawa T, Ishioka Y, Itoh T, Kugimiya A, Katayama K, Yamamoto T, Nagira M, Ishii KJ. Nakagawa T, et al. Among authors: nagira m. Front Immunol. 2021 Dec 23;12:803090. doi: 10.3389/fimmu.2021.803090. eCollection 2021. Front Immunol. 2021. PMID: 35003132 Free PMC article.
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Homma T, Nagata N, Hashimoto M, Iwata-Yoshikawa N, Seki NM, Shiwa-Sudo N, Ainai A, Dohi K, Nikaido E, Mukai A, Ukai Y, Nakagawa T, Shimo Y, Maeda H, Shirai S, Aoki M, Sonoyama T, Sato M, Fumoto M, Nagira M, Nakata F, Hashiguchi T, Suzuki T, Omoto S, Hasegawa H. Homma T, et al. Among authors: nagira m. Sci Rep. 2022 Dec 2;12(1):20861. doi: 10.1038/s41598-022-25418-5. Sci Rep. 2022. PMID: 36460696 Free PMC article.
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Homma T, Nagata N, Hashimoto M, Iwata-Yoshikawa N, Seki NM, Shiwa-Sudo N, Ainai A, Dohi K, Nikaido E, Mukai A, Ukai Y, Nakagawa T, Shimo Y, Maeda H, Shirai S, Aoki M, Sonoyama T, Sato M, Fumoto M, Nagira M, Nakata F, Hashiguchi T, Suzuki T, Omoto S, Hasegawa H. Homma T, et al. Among authors: nagira m. Sci Rep. 2024 Jan 31;14(1):2599. doi: 10.1038/s41598-024-52772-3. Sci Rep. 2024. PMID: 38297027 Free PMC article. No abstract available.
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.
Daiko H, Marafioti T, Fujiwara T, Shirakawa Y, Nakatsura T, Kato K, Puccio I, Hikichi T, Yoshimura S, Nakagawa T, Furukawa M, Stoeber K, Nagira M, Ide N, Kojima T. Daiko H, et al. Among authors: nagira m. Cancer Immunol Immunother. 2020 Nov;69(11):2247-2257. doi: 10.1007/s00262-020-02619-3. Epub 2020 Jun 4. Cancer Immunol Immunother. 2020. PMID: 32500232 Free PMC article. Clinical Trial.
39 results